Daiwa Securities Group Inc. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6
-14.3%
2170.0%0.00%
Q2 2023$7
-12.5%
2170.0%0.00%
Q1 2023$80.0%2170.0%0.00%
Q4 2022$8
-99.9%
217
+19.2%
0.00%
Q3 2022$6,000
+20.0%
1820.0%0.00%
Q2 2022$5,000
-16.7%
1820.0%0.00%
Q1 2022$6,000
+20.0%
1820.0%0.00%
Q4 2021$5,0000.0%1820.0%0.00%
Q3 2021$5,000
+66.7%
182
+83.8%
0.00%
Q2 2021$3,0000.0%990.0%0.00%
Q1 2021$3,000
+50.0%
990.0%0.00%
Q4 2020$2,000
-66.7%
99
-66.6%
0.00%
Q3 2020$6,000
+20.0%
2960.0%0.00%
Q2 2020$5,0000.0%2960.0%0.00%
Q1 2020$5,000
-28.6%
2960.0%0.00%
Q4 2019$7,000
-22.2%
296
-10.8%
0.00%
Q3 2019$9,000
-18.2%
3320.0%0.00%
Q2 2019$11,000
-8.3%
3320.0%0.00%
Q1 2019$12,000
+33.3%
332
+17.3%
0.00%
Q4 2018$9,000
-35.7%
2830.0%0.00%
Q3 2018$14,000
-17.6%
2830.0%0.00%
Q2 2018$17,000
-99.5%
283
-99.6%
0.00%
-100.0%
Q1 2018$3,159,00068,9830.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders